Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED

Sabra Healthcare REIT Inc (SBRA)SBRA

Upturn stock ratingUpturn stock rating
Sabra Healthcare REIT Inc
$18.24
Delayed price
Profit since last BUY27.64%
WEAK BUY
upturn advisory
BUY since 133 days
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

11/14/2024: SBRA (4-star) is a REGULAR-BUY. BUY since 133 days. Profits (27.64%). Updated daily EoD!

Analysis of Past Performance​

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: WEAK BUY
Historic Profit: 37.22%
Upturn Advisory Performance Upturn Advisory Performance3
Avg. Invested days: 60
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 3
Last Close 11/14/2024
Type: Stock
Today’s Advisory: WEAK BUY
Historic Profit: 37.22%
Avg. Invested days: 60
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 3
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 11/14/2024
Upturn Advisory Performance Upturn Advisory Performance3

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 4.35B USD
Price to earnings Ratio 44.85
1Y Target Price 19.59
Dividends yield (FY) 6.46%
Basic EPS (TTM) 0.41
Volume (30-day avg) 1943978
Beta 1.24
52 Weeks Range 11.87 - 19.70
Updated Date 11/20/2024
Company Size Mid-Cap Stock
Market Capitalization 4.35B USD
Price to earnings Ratio 44.85
1Y Target Price 19.59
Dividends yield (FY) 6.46%
Basic EPS (TTM) 0.41
Volume (30-day avg) 1943978
Beta 1.24
52 Weeks Range 11.87 - 19.70
Updated Date 11/20/2024

Earnings Date

Report Date 2024-10-31
When AfterMarket
Estimate 0.16
Actual 0.13
Report Date 2024-10-31
When AfterMarket
Estimate 0.16
Actual 0.13

Profitability

Profit Margin 14.22%
Operating Margin (TTM) 36.32%

Management Effectiveness

Return on Assets (TTM) 2.83%
Return on Equity (TTM) 3.46%

Revenue by Products

Revenue by Products - Current and Previous Year

Valuation

Trailing PE 44.85
Forward PE 8.71
Enterprise Value 6828889968
Price to Sales(TTM) 6.37
Enterprise Value to Revenue 9.98
Enterprise Value to EBITDA 17.8
Shares Outstanding 236587008
Shares Floating 233175223
Percent Insiders 1.17
Percent Institutions 99.2
Trailing PE 44.85
Forward PE 8.71
Enterprise Value 6828889968
Price to Sales(TTM) 6.37
Enterprise Value to Revenue 9.98
Enterprise Value to EBITDA 17.8
Shares Outstanding 236587008
Shares Floating 233175223
Percent Insiders 1.17
Percent Institutions 99.2

Analyst Ratings

Rating 4.14
Target Price 14.63
Buy -
Strong Buy 8
Hold 6
Sell -
Strong Sell -
Rating 4.14
Target Price 14.63
Buy -
Strong Buy 8
Hold 6
Sell -
Strong Sell -

AI Summarization

Comprehensive Overview of Sabra Healthcare REIT Inc.

Company Profile:

History and Background:

Sabra Healthcare REIT, Inc. (NASDAQ: SBRA) is a publicly traded real estate investment trust (REIT) founded in 2010. The company specializes in owning and operating senior housing and healthcare facilities in the United States and Canada, including skilled nursing, assisted living, and independent living properties. Sabra leases these facilities to third-party operators under long-term triple-net leases.

Core Business Areas:

  • Senior Housing: Owning and operating skilled nursing, assisted living, and independent living facilities.
  • Healthcare Facilities: Owning and operating specialty hospitals, medical office buildings, and other healthcare-related properties.
  • Investments: Making strategic investments in healthcare-related businesses and technologies.

Leadership Team and Corporate Structure:

  • Rick Matros, Chairman and Chief Executive Officer: Over 30 years of experience in the healthcare real estate industry.
  • Talya Nevo-Hacohen, President and Chief Operating Officer: Extensive experience in real estate finance and investment banking.
  • Andrew Wilhelm, Executive Vice President and Chief Investment Officer: Over 20 years of experience in real estate investment and development.

Top Products and Market Share:

Top Products:

  • Skilled nursing facilities: Approximately 60% of Sabra's portfolio.
  • Assisted living facilities: Around 25% of the portfolio.
  • Independent living facilities: Approximately 10%.
  • Specialty hospitals and medical office buildings: The remaining 5%.

Market Share:

Sabra is one of the largest owners and operators of skilled nursing facilities in the United States, holding a market share of approximately 5%. The company also has a significant presence in the assisted living and independent living markets.

Product Performance and Market Reception:

Sabra's properties have consistently achieved high occupancy rates, demonstrating strong demand for its services. The company's diversified portfolio and focus on triple-net leases provide stability and predictable income.

Total Addressable Market (TAM):

The TAM for senior housing and healthcare in the United States is estimated to be over $800 billion, with the aging population driving significant demand. This market is expected to continue growing in the coming years.

Financial Performance:

Recent Financials:

  • Revenue: $1.28 billion in 2022.
  • Net Income: $137.8 million in 2022.
  • Profit Margin: 10.8% in 2022.
  • Earnings per Share (EPS): $1.33 per share in 2022.

Year-over-Year Performance:

Sabra has experienced consistent revenue and earnings growth over the past several years. The company has also maintained a healthy balance sheet with low debt levels.

Cash Flow and Balance Sheet:

Sabra generates strong recurring cash flow from its triple-net leases, which allows the company to invest in acquisitions and growth initiatives while maintaining a healthy dividend payout.

Dividends and Shareholder Returns:

Dividend History:

Sabra has a history of consistent dividend payments, increasing its annual dividend payout by 15% in 2022.

Shareholder Returns:

Over the past five years

Growth Trajectory:

Historical Growth:

Sabra has experienced consistent growth through acquisitions and organic expansion over the past five to ten years.

Future Growth Projections:

The company expects to maintain its growth trajectory in the coming years, driven by rising demand in the senior housing and healthcare sectors.

Recent Initiatives:

Sabra is actively pursuing acquisitions and partnerships to expand its portfolio and enhance its service offerings.

Market Dynamics:

Current Trends:

The senior housing and healthcare industry is experiencing strong demand due to the aging population. Technological advancements are also creating new opportunities for innovation and service delivery.

Industry Position:

Sabra is well-positioned within the industry, with a diversified portfolio, strong financial performance, and experienced management team.

Adaptability:

The company has a proven track record of adapting to changing market conditions and embracing new technologies.

Competition:

Key Competitors:

  • Ventas, Inc. (VTR)
  • Welltower Inc. (WELL)
  • National Health Investors, Inc. (NHI)
  • Senior Housing Properties Trust (SNH)

Competitive Advantages:

Sabra's competitive advantages include its scale, low cost of capital, and expertise in senior housing and healthcare real estate.

Challenges and Opportunities:

Key Challenges:

  • Regulatory changes in the healthcare industry.
  • Rising labor costs.
  • Competition from other healthcare providers.

Potential Opportunities:

  • Expansion into new markets.
  • Development of innovative care models and technologies.
  • Partnerships with healthcare providers.

Recent Acquisitions:

Sabra's recent acquisitions include:

  • 2020: Acquisition of a portfolio of skilled nursing facilities in California for $200 million
  • 2021: Joint venture to develop a new assisted living community in Florida for $50 million
  • 2022: Acquisition of a medical office building in Texas for $30 million

These acquisitions have helped to expand Sabra's portfolio and enhance its geographic diversification.

AI-Based Fundamental Rating:

Rating:

7 out of 10

Justification:

Sabra has a solid financial performance, a diversified portfolio, and experienced management. The company is well-positioned within the industry and has a clear growth strategy. However, the company faces some challenges, including regulatory changes and rising labor costs.

Disclaimer:

This information should not be considered financial advice. Please conduct your own research and consult with a financial professional before making any investment decisions.

Sources:

Information for this overview was gathered from the following sources:

  • Sabra Healthcare REIT, Inc. website (sabrahealthcare.com)
  • Yahoo Finance (finance.yahoo.com/quote/SBRA)
  • SEC filings (sec.gov)
  • Market research reports

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About Sabra Healthcare REIT Inc

Exchange NASDAQ Headquaters Tustin, CA, United States
IPO Launch date 2002-04-02 Chairman, President & CEO Mr. Richard K. Matros
Sector Real Estate Website https://www.sabrahealth.com
Industry REIT - Healthcare Facilities Full time employees 48
Headquaters Tustin, CA, United States
Chairman, President & CEO Mr. Richard K. Matros
Website https://www.sabrahealth.com
Website https://www.sabrahealth.com
Full time employees 48

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities ("Senior Housing - Leased"), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements ("Senior Housing - Managed"), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures. As of September 30, 2023, Sabra's real estate properties held for investment included 37,606 beds/units, spread across the United States and Canada.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​